$390.29
96.0632.65%
Pre-Market: May 10, 9:24 AM EDT
15 minutes delayed
Comments
Loading...
Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) Stock Quotes, Forecast and News Summary
Bio-Rad Laboratories, Inc. Class B Common Stock Stock (NYSE: BIO/B) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / - |
| Day Range | - - - |
| 52 Wk Range | - - - |
| Market Cap | - |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NYSE |
| RSI | 0 |
| Short Interest | - |
| Days to Cover | - |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
N/A
Industry
N/A
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells produ...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
You can purchase shares of Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) through any online brokerage.
Who are Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) competitors?
Other companies in Bio-Rad Laboratories, Inc. Class B Common Stock’s space includes: Medpace Hldgs (NASDAQ:MEDP), Agilent Technologies (NYSE:A), 10x Genomics (NASDAQ:TXG), BioLife Solns (NASDAQ:BLFS) and Waters (NYSE:WAT).
What is the target price for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
There is no analysis for Bio-Rad Laboratories, Inc. Class B Common Stock.
What is the forecast for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) stock?
Bio-Rad Laboratories, Inc. Class B Common Stock has a consensus price target of $436.67.
Current stock price for Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B)?
The stock price for Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO/B) is $390.29 last updated May 10, 2023 at 9:24 AM EDT.
Does Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) pay a dividend?
A quarterly cash dividend of 0.00 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on Invalid DateTime.
When is Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE:BIO/B) reporting earnings?
Bio-Rad Laboratories, Inc. Class B Common Stock’s Q3 earnings are confirmed for Thursday, October 24, 2024.
Is Bio-Rad Laboratories, Inc. Class B Common Stock (BIO/B) going to split?
There is no upcoming split for Bio-Rad Laboratories, Inc. Class B Common Stock.